Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue

Journal of Steroid Biochemistry and Molecular Biology

Volumn 95, Issue 1-5, 2005, Pages 17-23

  Chen, Shiuan ^a   Ye, Jingjing ^a   Kijima, Ikuko ^a   Kinoshita, Yoshiyuki ^a   Zhou, Dujin ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Aromatase; Breast cancer; Cancer tissue; Promoter I.3; Transcriptional regulation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; ACTIVATING TRANSCRIPTION FACTOR 2; AROMATASE; AROMATASE INHIBITOR; BISINDOLYLMALEIMIDE; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; COMPLEMENTARY DNA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2 INHIBITOR; ESTROGEN RECEPTOR; FULVESTRANT; GO 6979; LETROZOLE; PROTEIN KINASE C DELTA; PROTEIN KINASE INHIBITOR; RETINOIC ACID RECEPTOR GAMMA; ROTTLERIN; TAMOXIFEN;

BINDING SITE; BREAST CANCER; CELL DIFFERENTIATION; CONFERENCE PAPER; DNA FOOTPRINTING; DNA SEQUENCE; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE DELETION; GENE EXPRESSION; GENE LIBRARY; GENE REPRESSION; GENETIC SCREENING; GENETIC TRANSFECTION; HUMAN; IN VIVO STUDY; MOLECULAR MECHANICS; MUTATIONAL ANALYSIS; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; TRANSCRIPTION REGULATION; UPREGULATION;

AROMATASE; BREAST NEOPLASMS; DNA FOOTPRINTING; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION;

GASTROPODA; MINK CELL FOCUS-FORMING VIRUS;

EID: 23744492069     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.04.002     Document Type: Conference Paper

References (31)

1. The ATAC (Arimidex Tamoxifen alone or in Combination) Trialists' Group Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial Lancet 359 2002 2131 2139
2. E.P. Winer, C. Hudis, H.J. Burstein, R.T. Chlebowski, J.N. Ingle, S.B. Edge, E.P. Mamounas, J. Gralow, L.J. Goldstein, K.I. Pritchard, S. Braun, M.A. Cobleigh, A.S. Langer, J. Perotti, T.J. Powles, T.J. Whelan, and G.P. Browman American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002 J. Clin. Oncol. 20 2002 3317 3327
3. M.J. Ellis, A. Coop, B. Singh, L. Mauriac, A. Llombert-Cussac, F. Janicke, W.R. Miller, D.B. Evans, M. Dugan, C. Brady, E. Quebe-Fehling, and M. Borgs Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial J. Clin. Oncol. 19 2001 3808 3816
4. P.E. Goss, J.N. Ingle, S. Martino, N.J. Robert, H.B. Muss, M.J. Piccart, M. Castiglione, D. Tu, L.E. Shepherd, K.I. Pritchard, R.B. Livingston, N.E. Davidson, L. Norton, E.A. Perez, J.S. Abrams, P. Therasse, M.J. Palmer, and J.L. Pater A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer New Engl. J. Med. 349 2003 1793 1802
5. R.C. Coombes, E. Hall, L.J. Gibson, R. Paridaens, J. Jassem, T. Delozier, S.E. Jones, I. Alvarez, G. Bertelli, O. Ortmann, A.S. Coates, E. Bajetta, D. Dodwell, R.E. Coleman, L.J. Fallowfield, E. Mickiewicz, J. Andersen, P.E. Lonning, G. Cocconi, A. Stewart, N. Stuart, C.F. Snowdon, M. Carpentieri, G. Massimini, and J.M. Bliss A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer New Engl. J. Med. 350 2004 1081 1092
6. J.M. Esteban, Z. Warsi, M. Haniu, P.F. Hall, J.E. Shively, and S. Chen Detection of intratumoral aromatase in breast carcinomas, an immunohistochemical study with clinico-pathologic correlation J. Am. Pathol. 140 1992 337 343
7. X.Z. Sun, D. Zhou, and S. Chen Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells J. Steroid Biochem. Mol. Biol. 63 1997 29 36
8. S.E. Bulun, S. Sebastian, K. Takayama, T. Suzuki, H. Sasano, and M. Shozu The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters J. Steroid Biochem. Mol. Biol. 86 2003 219 224
9. C. Zhou, D. Zhou, J. Esteban, J. Murai, P.K. Siiteri, S. Wilczynski, and S. Chen Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction (RT-PCR) J. Steroid Biochem. Mol. Biol. 59 1996 163 171
10. S.E. Bulun, L.S. Noble, K. Takayama, M.D. Michael, V. Agarwal, C. Fisher, Y. Zhao, M.M. Hinshelwood, Y. Ito, and E.R. Simpson Endocrine disorders associated with inappropriately high aromatase expression J. Steroid Biochem. Mol. Biol. 61 1997 133 139
11. N. Harada A unique aromatase (P-450arom) mRNA formed by alternative use of tissue-specific exons 1 in human skin fibroblasts Biochem. Biophys. Res. Commun. 189 1993 1001 1007
12. M.S. Mahendroo, C.R. Mendelson, and E.R. Simpson Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue J. Biol. Chem. 268 1993 19463 19470
13. Y. Zhao, C.R. Mendelson, and E.R. Simpson Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes Mol. Endocrinol. 9 1995 340 349
14. D. Zhou, and S. Chen Characterization of a silencer element in the human aromatase gene Arch. Biochem. Biophys. 353 1998 213 220
15. C. Yang, D. Zhou, and S. Chen Modulation of aromatase expression in the breast tissue by ERRα-1 orphan receptor Cancer Res. 58 1998 5695 5700
16. C. Yang, B. Yu, D. Zhou, and S. Chen Regulation of aromatase promoter activity in human breast tissue by nuclear receptors EAR-2, COUP-TF1 (EAR-3), and RARγ Oncogene 21 2002 2854 2863
17. S. Chen, D. Zhou, C. Yang, and M. Sherman Molecular basis for the constitutive activity of estrogen related receptor α-1 (ERRα-1) J. Biol. Chem. 276 2001 28465 28470
18. C. Yang, and S. Chen Two organochlorine pestides, toxaphene and chlordane, are antagonists for ERRα-1 orphan receptor Cancer Res. 59 1999 4519 4524
19. M. Suetsugi, L. Su, K. Karlsberg, Y.-C. Yuan, and S. Chen Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors Mol. Cancer Res. 1 2003 981 991
20. D. Zhou, and S. Chen Identification and characterization of a cAMP-responsive element in the region upstream from promoter I.3 of the human aromatase gene Arch. Biochem. Biophys. 371 1999 179 190
21. T. Okubo, T.K. Truong, B. Yu, T. Itoh, B. Grube, D. Zhou, and S. Chen Down-regulation of promoter I.3 activity of the human aromatase gene in breast tissue by zinc-finger protein, Snail (SnaH) Cancer Res. 61 2001 1338 1346
22. S. Chen, T. Itoh, K. Wu, D. Zhou, and C. Yang Transcriptional regulation of aromatase expression in human breast tissue J. Steroid Biochem. Mol. Biol. 83 2002 93 99
23. Y. Zhao, V.R. Agarwal, C.R. Mendelson, and E.R. Simpson Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture J. Steroid Biochem. Mol. Biol. 61 1997 203 210
24. S.M. Aronica, W.L. Kraus, and B.S. Katzenellenbogen Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription Proc. Natl. Acad. Sci. U.S.A. 91 1994 8517 8521
25. K. Zeitoun, K. Takayama, M.D. Michael, and S.E. Bulun Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element Mol. Endocrinol. 13 1999 239 253
26. C.D. Clyne, C.J. Speed, J. Zhou, and E.R. Simpson Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes J. Biol. Chem. 277 2002 20591 20597
27. Y. Kinoshita, and S. Chen Induction of aromatase (CYP19) expression in breast cancer cells through a non-genomic action of ER alpha Cancer Res. 63 2003 3546 3555
28. V.G. Keshamouni, R.R. Mattingly, and K.B. Reddy Mechanism of 17-β-estradiol-induced Erk 1/2 activation in breast cancer cells. A role for her2 and PKC-δ J. Biol. Chem. 277 2002 22558 22565
29. S. Dai, H. Chen, C. Chang, A.D. Riggs, and S.D. Flanagan Ligation-mediated PCR for quantitative in vivo footprinting Nat. Biotechnol. 18 2000 1108 1111
30. N. Fujita, D.L. Jaye, M. Kajita, C. Geigerman, C.S. Moreno, and P.A. Wade MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer Cell 113 2003 207 219
31. J. Gotzmann, H. Huber, C. Thallinger, M. Wolschek, B. Jansen, R. Schulte-Hermann, H. Beug, and W. Mikulits Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness J. Cell Sci. 115 2002 1189 1202